Cadrenal Therapeutics logo

Cadrenal Therapeutics Share Price (NASDAQ: CVKD)

$12.92

-0.37

(-2.78%)

Live

Last updated on

Check the interactive Cadrenal Therapeutics Stock chart to analyse performance

Cadrenal Therapeutics stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$12.92
    Today's High:$13.15

    Day's Volatility :1.75%

  • 52 Weeks Low:$6.89
    52 Weeks High:$22.90

    52 Weeks Volatility :69.91%

Cadrenal Therapeutics Stock Returns

PeriodCadrenal Therapeutics IncIndex (Russel 2000)
3 Months
-0.23%
0.0%
6 Months
-30.0%
0.0%
1 Year
79.97%
0.0%
3 Years
-78.48%
-6.1%

Cadrenal Therapeutics Inc Key Stats

Check Cadrenal Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$13.29
Open
$13.13
Today's High
$13.15
Today's Low
$12.66
Market Capitalization
$28.5M
Today's Volume
$35.9K
52 Week High
$22.9011
52 Week Low
$6.89
Revenue TTM
$0.0
EBITDA
$-14.4M
Earnings Per Share (EPS)
$-8.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-340.31%

Stock Returns calculator for Cadrenal Therapeutics Stock including INR - Dollar returns

The Cadrenal Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cadrenal Therapeutics investment value today

Current value as on today

₹1,80,008

Returns

₹80,008

(+80.01%)

Returns from Cadrenal Therapeutics Stock

₹74,831 (+74.83%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Cadrenal Therapeutics Stock

-43%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Cadrenal Therapeutics Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Cadrenal Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Cadrenal Therapeutics(by analysts ranked 0 to 5 stars)

Cadrenal Therapeutics Share Price Target

What analysts predicted

Upside of 176.06%

Target:

$35.67

Current:

$12.92

Cadrenal Therapeutics share price target is $35.67, a slight Upside of 176.06% compared to current price of $12.92 as per analysts' prediction.

Cadrenal Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, CVKD stock has moved up by 6.6%

Cadrenal Therapeutics Technicals Summary

Sell

Neutral

Buy

Cadrenal Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Cadrenal Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cadrenal Therapeutics Inc logo
26.19%
-30.0%
79.97%
-78.48%
-78.48%
Regeneron Pharmaceuticals, Inc. logo
3.77%
-17.64%
-51.18%
-2.19%
-7.17%
Beone Medicines Ltd logo
-0.02%
10.33%
51.07%
81.16%
24.14%
Vertex Pharmaceuticals Incorporated logo
-16.39%
-18.24%
-20.49%
39.42%
40.54%
Alnylam Pharmaceuticals, Inc. logo
33.05%
83.22%
57.52%
115.32%
240.85%

About Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Organization
Cadrenal Therapeutics
Employees
4
CEO
Mr. Quang X. Pham
Industry
Miscellaneous

Key Management of Cadrenal Therapeutics Inc

NameTitle
Mr. Quang X. Pham
Chairman & CEO
Mr. Matthew K. Szot CPA, CPA
Co-Founder & CFO
Mr. Jeffrey Cole
Chief Operating Officer
Dr. James J. Ferguson FACC, M.D.
Chief Medical Officer

Important FAQs about investing in CVKD Stock from India :

What is Cadrenal Therapeutics share price today?

Cadrenal Therapeutics share price today is $12.92 as on . Cadrenal Therapeutics share today touched a day high of $13.15 and a low of $12.92.

What is the 52 week high and 52 week low for Cadrenal Therapeutics share?

Cadrenal Therapeutics share touched a 52 week high of $22.90 and a 52 week low of $6.89. Cadrenal Therapeutics stock price today i.e. is trending at $12.92, lower by 43.58% versus the 52 week high.

How to invest in Cadrenal Therapeutics Stock (CVKD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cadrenal Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cadrenal Therapeutics Shares that will get you 0.1161 shares as per Cadrenal Therapeutics share price of $12.92 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cadrenal Therapeutics Stock (CVKD) from India?

Indian investors can start investing in Cadrenal Therapeutics (CVKD) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Cadrenal Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Cadrenal Therapeutics share’s latest price of $12.92 as on August 30, 2025 at 1:28 am IST, you will get 0.7740 shares of Cadrenal Therapeutics. Learn more about fractional shares .

What are the returns that Cadrenal Therapeutics has given to Indian investors in the last 5 years?

Cadrenal Therapeutics stock has given -78.48% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?